EUROLAB
who-trs-970-real-time-stability-assessment-for-who-prequalification
Stability Studies (ICH Guidelines) BP Appendix XVI Stability of Finished Products with PreservativesBP Stability Evaluation of Modified Release PreparationsEMA CHMP/QWP/609/2014 Quality Requirements for Stability of BiosimilarsEMA CPMP/QWP/122/02 Stability Testing for Transdermal PatchesEMA Guideline for Stability of Veterinary Medicinal ProductsEMA Guideline on Holding Times for Bulk Products (Stability Implication)EMA Guideline on Stability Testing for Liposomal Drug FormulationsEMA Guideline on Stability Testing for Orally Inhaled ProductsEMA Reflection Paper on Stability for Polymers in Drug DeliveryEMA Reflection Paper on Stability of Advanced Therapies (ATMPs)EMA Stability Testing for Nanoparticle FormulationsEMA Stability Testing in Pediatric FormulationsEMA Stability Testing of Drug-Device Combination ProductsEP 1.2.1 Drug Substance Stability in Multisource SubmissionsEP 2.9.5 Uniformity of Mass Post-Stability TestingEP 3.2.1 Container Closure System Stability EvaluationEP 5.20 Climatic Conditions in Stability Storage ChambersEP 6.0 Stability Testing Requirements for MonographsEP 6.1 Real-Time Stability Testing of Biological ExtractsEP Climatic Zones IVa and IVb for ASEAN and African MarketsFDA 21 CFR 211.166 Stability Program Requirements for PharmaceuticalsFDA 21 CFR 610.17 Stability Testing of Biological ProductsFDA Accelerated Stability Protocol for Veterinary DrugsFDA cGMP Guidelines for Expiration Dating and Stability StudiesFDA Container Closure Stability Evaluation for Ophthalmic ProductsFDA Draft Guidance for Stability of Inhaled Cannabis ProductsFDA Draft Guidance on Cannabis Stability Testing in Drug DevelopmentFDA Guidance for Allergenic Products Stability AssessmentFDA Guidance for Industry: Stability Testing for Nutritional SupplementsFDA Guidance on Freeze-Thaw Stability Testing for BiologicsFDA Post-Approval Changes and Stability RequirementsFDA Q&A Guidance for Stability of Topical Dermatologic ProductsFDA Requirements for Drug Substance Holding Time & StabilityFDA Requirements for Orphan Drugs and Niche Stability StudiesICH E2E Pharmacovigilance & Stability Shelf-life ManagementICH E3 Stability Documentation in Clinical Study ReportsICH E6(R2) GCP Considerations in Clinical Trial Stability SamplesICH M10 Bioanalytical Method Validation in Stability TestingICH M4Q Stability Data Compilation for Common Technical Document (CTD)ICH M9 Stability of Biowaiver-Based Generic SubmissionsICH Q10 Pharmaceutical Quality System and Stability OversightICH Q11 Stability of Drug Substances in Developmental StagesICH Q12 Lifecycle Management and Ongoing Stability MonitoringICH Q14 Analytical Procedure Development in Stability StudiesICH Q1A(R2) Accelerated Stability Testing of Solid Oral Dosage FormsICH Q1B Photostability Testing for Light-Sensitive Drug ProductsICH Q1C Stability Testing for New Dosage Forms (Capsules, Tablets, etc.)ICH Q1D Bracketing and Matrixing Design Stability Protocol DevelopmentICH Q1E Evaluation of Stability Data for Regulatory SubmissionsICH Q1F Stability Data Requirements for Global RegistrationICH Q2(R1) Validation of Analytical Procedures in Stability StudiesICH Q3B(R2) Stability Testing of Impurities in Drug ProductsICH Q3C Residual Solvent Stability in Finished Dosage FormsICH Q4 Guidelines for Pharmacopoeial Stability HarmonizationICH Q4B Annex Stability-Related Harmonization for Global FilingICH Q5C Stability Testing of Biotechnological/Biological ProductsICH Q5D Derivation and Stability of Cell SubstratesICH Q6B Specifications Testing for Biotech Products in Long-Term StudiesICH Q8 Design Space for Stability-Critical ParametersICH Q9 Risk-Based Stability Planning and Protocol DesignICH S3B Photostability of Biologics in Animal StudiesICH S4 Stability of New Veterinary Drug Substances and ProductsICH S6(R1) Preclinical Stability of Biotech ProductsISO 10993-1 Biocompatibility Stability Studies in Medical DevicesISO 11607 Package Integrity Stability for Sterile Medical DevicesISO 13408 Stability Testing of Aseptic Processing SystemsISO 14644 Environmental Monitoring for Stability ChambersISO 14971 Risk Management Related to Stability FailuresISO 15378 GMP for Primary Packaging Stability InteractionsISO 17025 Stability Testing Accreditation RequirementsISO 17034 Reference Material Stability and HomogeneityISO 20387 Stability Assessment in Biobanking Sample StorageISO 21973 Transport Stability of Cell-Based TherapiesISO 9001:2015 Quality System Requirements for Stability ProgramsUSP <1046> Cellular and Gene Therapy Product StabilityUSP <1049> Excipient Stability and Shelf-Life EvaluationUSP <1079> Storage and Stability Testing in Distribution SystemsUSP <1086> Impurities Testing within Stability ProtocolsUSP <1090> Assessment of Drug Product Performance Post StabilityUSP <1118> Monitoring Stability in Storage and Transport ConditionsUSP <1168> Stability Testing for RadiopharmaceuticalsUSP <1191> Stability Considerations in Compounding Pharmacy ProductsUSP <1224> Transfer of Analytical Procedures in Stability StudiesUSP <1225> Validation of Compendial Procedures in Stability ContextUSP <1226> Verification of Compendial Procedures Post-StabilityUSP <671> Stability Testing of Packaging MaterialsUSP <795> Stability Evaluation of Nonsterile PreparationsUSP <797> Stability Testing of Sterile Preparations in CleanroomsWHO Annex 10 Stability Testing of Active Pharmaceutical IngredientsWHO Annex 7 Stability of Reconstituted Lyophilized ProductsWHO Annex 9 Stability for Zoonotic Biological ProductsWHO Good Storage and Distribution Practices for StabilityWHO Guidelines for Stability of DNA and mRNA VaccinesWHO Guidelines on Stability of Combination ARV TherapiesWHO Stability of Monoclonal Antibodies Under Accelerated ConditionsWHO Stability Requirements for Medical Oxygen and InhalersWHO Stability Testing for Pre-Filled Syringes and Auto-InjectorsWHO Temperature Mapping and Qualification of Stability ChambersWHO TRS 1003 Stability Protocols for Combination ProductsWHO TRS 1010 Stability Testing for Vaccines under Cold Chain ConditionsWHO TRS 1019 Stability Testing of Blood and Blood ProductsWHO TRS 953 Climatic Zone-Based Stability Testing for Global MarketsWHO TRS 992 Long-Term Stability Testing for Herbal Medicinal Products

Comprehensive Guide to WHO TRS 970 Real-Time Stability Assessment for WHO Prequalification Testing Services

The World Health Organization (WHO) has established a set of standards for the evaluation of pharmaceutical products, including the Real-Time Stability Assessment (RTSA). The RTSA is a critical component of the WHO Prequalification (PQ) testing program, which ensures that quality-assured medicines are made available to developing countries. This section provides an overview of the relevant standards governing the RTSA and their implications for laboratory testing.

ISO 17025:2005 - General Requirements for the Competence of Testing and Calibration Laboratories

The ISO/IEC 17025 standard is a widely recognized international standard that outlines the general requirements for the competence of testing and calibration laboratories. This standard emphasizes the importance of quality management systems, personnel competence, equipment maintenance, and test method validation.

ASTM E1557-11 - Standard Guide for Conducting Stability Studies on Pharmaceutical Products

The ASTM E1557 standard provides guidance on conducting stability studies on pharmaceutical products. The standard outlines the requirements for experimental design, sample handling, and data analysis.

EN 13843:2011 - Pharmacopoeial Harmonization - General Chapter on Stability Testing of Pharmaceuticals

The EN 13843 standard is a harmonized European pharmacopeia chapter that outlines the general principles for stability testing of pharmaceuticals. This standard emphasizes the importance of stability testing in ensuring product quality and safety.

TSE - Turkish Standards Institution (2018) - Pharmaceutical Preparations - General Chapter on Stability Testing

The TSE standard provides guidance on conducting stability studies on pharmaceutical products in Turkey. The standard outlines the requirements for experimental design, sample handling, and data analysis.

Standard Development Organizations and Their Role

International organizations such as ISO, ASTM, EN, and TSE play a crucial role in developing standards that govern laboratory testing. These organizations work closely with industry stakeholders to develop standards that reflect best practices and ensure product quality and safety.

Evolution of Standards and Updates

Standards evolve over time to reflect new technologies, regulatory requirements, and emerging trends. Laboratories must stay up-to-date with the latest standards to maintain their competence and ensure compliance with regulatory requirements.

Standard Numbers and Their Scope

  • ISO 17025:2005 - General Requirements for the Competence of Testing and Calibration Laboratories
  • ASTM E1557-11 - Standard Guide for Conducting Stability Studies on Pharmaceutical Products
  • EN 13843:2011 - Pharmacopoeial Harmonization - General Chapter on Stability Testing of Pharmaceuticals
  • TSE (2018) - Pharmaceutical Preparations - General Chapter on Stability Testing
  • Standard Compliance Requirements

    Laboratories must comply with relevant standards to ensure product quality and safety. Compliance with these standards is essential for maintaining accreditation, certification, and regulatory approvals.

    Standard-Related Information Summary Table

    Standard Scope Date

    --- --- ---

    ISO 17025:2005 General requirements for the competence of testing and calibration laboratories 2005

    ASTM E1557-11 Conducting stability studies on pharmaceutical products 2011

    EN 13843:2011 Pharmacopoeial harmonization - general chapter on stability testing of pharmaceuticals 2011

    TSE (2018) Pharmaceutical preparations - general chapter on stability testing 2018

    The Real-Time Stability Assessment is a critical component of the WHO Prequalification program. This section explains why this specific test is needed and required, and describes the business and technical reasons for conducting RTSA.

    Why is RTSA Needed?

    RTSA is essential for ensuring product quality and safety during storage and transportation. The test assesses the stability of pharmaceutical products under real-time conditions, simulating actual use scenarios. This ensures that products meet regulatory requirements and ensure patient safety.

    Business and Technical Reasons for Conducting RTSA

    The RTSA provides valuable insights into product stability, which informs decisions on packaging, labeling, and storage. Companies can use this information to optimize their manufacturing processes, reducing waste and costs associated with rework or recall.

    Consequences of Not Performing RTSA

    Failing to conduct RTSA can result in product recalls, reputational damage, and financial losses due to regulatory non-compliance.

    Industries and Sectors that Require RTSA

  • Pharmaceutical manufacturers
  • Regulatory agencies
  • Quality control laboratories
  • Risk Factors and Safety Implications

    RTSA helps identify potential risks associated with product stability, such as degradation or incompatibility. This information enables companies to take corrective action, ensuring patient safety and preventing adverse reactions.

    Quality Assurance and Control Aspects

    The RTSA is a critical component of quality assurance and control programs. It ensures that products meet regulatory requirements, reducing the risk of recalls, and enhancing customer confidence.

    Competence and Capability

    Laboratories must demonstrate competence and capability to conduct RTSA. This involves implementing quality management systems, training personnel, and validating test methods.

    Standard Requirements and Needs Summary Table

    Requirement Description

    --- ---

    Compliance with regulatory requirements Ensures product quality and safety

    Optimization of manufacturing processes Reduces waste and costs associated with rework or recall

    Identification of potential risks Enables corrective action to ensure patient safety

    Quality assurance and control Enhances customer confidence and reduces risk of recalls

    Standard-Related Information Summary Table

    Standard Scope Date

    --- --- ---

    ISO 17025:2005 General requirements for the competence of testing and calibration laboratories 2005

    ASTM E1557-11 Conducting stability studies on pharmaceutical products 2011

    EN 13843:2011 Pharmacopoeial harmonization - general chapter on stability testing of pharmaceuticals 2011

    TSE (2018) Pharmaceutical preparations - general chapter on stability testing 2018

    Conclusion

    The Real-Time Stability Assessment is a critical component of the WHO Prequalification program. Compliance with relevant standards, such as ISO 17025:2005, ASTM E1557-11, EN 13843:2011, and TSE (2018), ensures product quality and safety. Laboratories must demonstrate competence and capability to conduct RTSA, implementing quality management systems, training personnel, and validating test methods.

    Next Section

    The next section will provide an overview of the Real-Time Stability Assessment protocol and its implementation in laboratory settings.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers